Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-10-25 | Centessa Pharmaceuticals plc | Weinhoff Gregory M
(Chief Business Officer) |
S | Ordinary Shares | D | 11742 | $15.38 - $15.38 | $180,628 |
| 2024-10-21 | Centessa Pharmaceuticals plc | SAHA SAURABH
(Chief Executive Officer) |
S | Ordinary Shares | D | 55000 | $15.32 - $15.80 | $863,726 |
| 2024-09-25 | Centessa Pharmaceuticals plc | Weinhoff Gregory M
(Chief Business Officer) |
S | Ordinary Shares | D | 16619 | $15.69 - $15.69 | $260,723 |
| 2024-09-20 | Centessa Pharmaceuticals plc | SAHA SAURABH
(Chief Executive Officer) |
S | Ordinary Shares | D | 55000 | $16.53 - $16.53 | $908,985 |
| 2024-09-10 | Centessa Pharmaceuticals plc | Weinhoff Gregory M
(Chief Business Officer) |
S | Ordinary Shares | D | 30000 | $17.00 - $17.00 | $510,000 |
| 2024-09-10 | Centessa Pharmaceuticals plc | Weinhoff Gregory M
(Chief Business Officer) |
M | Ordinary Shares | A | 30000 | $5.84 - $5.84 | $175,200 |
| 2024-09-10 | Centessa Pharmaceuticals plc | SAHA SAURABH
(Chief Executive Officer) |
S | Ordinary Shares | D | 175000 | $16.52 - $16.52 | $2,891,822 |
| 2024-09-10 | Centessa Pharmaceuticals plc | SAHA SAURABH
(Chief Executive Officer) |
M | Ordinary Shares | A | 175000 | $5.84 - $5.84 | $1,022,000 |
| 2024-09-09 | Centessa Pharmaceuticals plc | Weinhoff Gregory M
(Chief Business Officer) |
S | Ordinary Shares | D | 25000 | $15.00 - $15.00 | $375,000 |
| 2024-09-09 | Centessa Pharmaceuticals plc | Weinhoff Gregory M
(Chief Business Officer) |
M | Ordinary Shares | A | 25000 | $5.84 - $5.84 | $146,000 |
| 2024-08-23 | Centessa Pharmaceuticals plc | SAHA SAURABH
(Chief Executive Officer) |
S | Ordinary Shares | D | 46651 | $12.30 - $12.30 | $573,905 |
| 2024-08-22 | Centessa Pharmaceuticals plc | Weinhoff Gregory M
(Chief Business Officer) |
S | Ordinary Shares | D | 30000 | $12.17 - $12.29 | $367,221 |
| 2024-08-20 | Centessa Pharmaceuticals plc | SAHA SAURABH
(Chief Executive Officer) |
S | Ordinary Shares | D | 8349 | $12.23 - $12.32 | $102,545 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |